Research Projects All Projects
Projects

Quick links

Oligomer – Focused Screening and Individualized Therapeutics to target Neurodegenerative Disoders” (OligoFIT)

 

 

 

 

 

Project Title: Oligomer – Focused Screening and Individualized Therapeutics to target Neurodegenerative Disoders” (OligoFIT)

Funding: JPND call for proposals: “Multinational research projects on Personalised Medicine for Neurodegenerative Diseases”

Project Nr.:  OligoFIT – PRL/20/9

Period: 36 months  01.04.2020.-31.03.2023.

Project funding: EUR 210 000.00

Partners: University of Oxford, University Medical Center Göttingen, University of Aarhus, Polytechnic School of Porto, University of Warsaw

 

Coordinator: Prof Martin Bachmann, University of Oxford

BMC Principle Investigator:  K.Tārs

Project description:

The overall aim of OligoFIT is to detect pathological alpha-synuclein oligomer components with relevance to Lewi-body disease severity/status. Detected oligomers will be further used for development of biosensor-based diagnostics and therapeutic vaccine candidates.

BMC main task in this project is design, characterization and preclinical immunogenicity studies of therapeutic VLP-based vaccine candidate.

Information published 01.04.2020.



Mājas lapas izstrādi finansēja ERAF 2.1.1.2. aktivitātes projekts Nr. 2010/0196/2DP/2.1.1.2.0/10/APIA/VIAA/004 "Latvijas biomedicīnas pētījumu integrācija Eiropas zinātnes telpā".